Table 1.
Patients | HC | p-value | |
---|---|---|---|
Subjects, n | 77 | 20 | / |
Gender, males/females | 45/32 | 10/10 | 0.499 |
Age, y | 35(18-71) | 27(18-52) | 0.053 |
ALT, IU/L | 75(15-942) | 15(7-31) | <0.001 |
AST, IU/L | 51(13-915) | 14.5(7-34) | <0.001 |
HBV DNA, log10 IU/mL | 6.72(0-8.38) | NA | / |
HBsAg, log10 IU/mL | 3.50(1.30-4.72) | NA | / |
HBeAg, positive/negative, n | 39/38 | 0/20 | <0.001 |
ALT, elevated/normal, n | 40/37 | 0/20 | <0.001 |
Abbreviations. ALT: alanine transaminase; AST: aspartate aminotransferase; HBeAg: hepatitis B e antigen; HBsAg: hepatitis B s antigen; HBV: hepatitis B virus; HC: healthy controls; NA: not applicable.
(a) Values are expressed as the median (minimum-maximum) for age, ALT, AST, and HBV DNA.
(b) HBV DNA<100 was treated as 0 log10 IU/ml.